A detailed history of Entry Point Capital, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Entry Point Capital, LLC holds 1,129 shares of DXCM stock, worth $77,799. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,129
Holding current value
$77,799
% of portfolio
0.19%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$110.31 - $140.45 $124,539 - $158,568
1,129 New
1,129 $128 Million
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $81,831 - $134,589
1,084 New
1,084 $135 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.6B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Entry Point Capital, LLC Portfolio

Follow Entry Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entry Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Entry Point Capital, LLC with notifications on news.